⌕
Alumis · ALMS · Nasdaq
Tenet 55 · Mixed
Compare
$5.14−8.21%At closeTenet 55 · Mixed
$5.14−0.46 (−8.21%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Alumis (ALMS) Stock

Alumis (ALMS) closed at $5.14 on Nov 16, 2026; its Tenet Score is 55 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$5.14
Nov 16, 2026
Market cap
$667.3M
share price × the latest quarter's diluted weighted-average share count (vendor)
Dividend yield
0.00%
reinvests all
52-week range
4.60 – 31.35
low → high
Tenet Score
55/100
Mixed · 409 Healthcare peers

Industry: Pharmaceutical Preparations · see every company filed here →

Alumis Inc. scores 55/100. Mixed. Strongest on value and financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 55 is built from 3 of 4 pillars, from 45% of its inputs. Growth is left out because no growth rate could be measured.

Tenet Score · vs sector

n=409
55/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
80
Quality
10
Health
75
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueBQualityFHealthBGrowth—MomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
1.9×
cap ÷ Sep 30, 2026 book value, Nov 13, 2026 close
P/S
30.2×
price to fiscal 2025 sales
ROE
−111%
TTM through Sep 30, 2026
Operating margin
−1886.9%
fiscal 2025, before interest and tax
Net margin
—
Not reported in the company's filings for this period.
Current ratio
5.57
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 3y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Alumis Inc.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Our name, Alumis, captures our mission to enlighten immunology, and is inspired by the words "allumer"-French for illuminate-and "imm…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 54 US ETFs · top wrappers by weightSee all ETFs holding ALMS →

Similar-sized companies in Pharmaceutical Preparations

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Alumis in?

Alumis is in the Healthcare sector and the Pharmaceutical Preparations industry.

What is Alumis' Tenet Score?

Alumis' Tenet Score is 55 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.